People Background Check
Find People:

Joseph B Bogardus, Age 76892 Hurricane Rd, Keene, NY 12942

Get Report
Known as:
Joseph Ballard Bogardus Joseph L Bogardus Joe L Bogardus Ben J Bogardus

Joseph Bogardus Phones & Addresses

892 Hurricane Rd, Keene, NY 12942

Indian Lake, NY

18 Alta Vista Dr, Princeton, NJ 08540

Manlius, NY

Groton, CT

Mentions for Joseph B Bogardus

Joseph Bogardus resumes & CV records

Resumes

Joseph Bogardus Photo 19

Financial Planner At Barnum Financial Group

Joseph Bogardus Photo 20

Consultant

Location:
P/O Box 165, Keene, NY
Industry:
Pharmaceuticals
Work:
Keenepharma
Consultant Bristol-Myers Squibb 1984 - 2005
Executive Director, Pharmaceutics R and D
Education:
The University of Kansas
Doctorates, Doctor of Philosophy, Chemistry University of Kentucky
Bachelors, Bachelor of Science, Chemistry
Skills:
Pharmaceutical Development
Joseph Bogardus Photo 21

Director Of Client Services At Mary Beth West Consulting

Publications & IP owners

Wikipedia

Joseph Bogardus Photo 22

New York State Electi 1893

They nominated Joseph A. Bogardus, of New York City, for Secretary of State; George Chester, of Buffalo, for Comptroller; William R. Hunt of Honeoye Falls, ...

Us Patents

Pharmaceutical Compositions Of Orally Active Taxane Derivatives Having Enhanced Bioavailability

US Patent:
2003022, Nov 27, 2003
Filed:
Dec 19, 2002
Appl. No.:
10/323551
Inventors:
Joseph Bogardus - Princeton NJ, US
Robert Perrone - Belle Mead NJ, US
Krishnaswamy Raghavan - Cranbury NJ, US
Sailesh Varia - Princeton Junction NJ, US
International Classification:
A61K031/337
US Classification:
514/449000
Abstract:
Disclosed are pharmaceutical compositions which comprise an orally-active taxane derivative and a pharmaceutically acceptable solubilizing agent, and which provide effective and consistent oral absorption of the taxane derivative.

Etoposide Solution In Nmp

US Patent:
4772589, Sep 20, 1988
Filed:
Oct 29, 1986
Appl. No.:
6/924463
Inventors:
Murray A. Kaplan - Syracuse NY
Robert K. Perrone - Liverpool NY
Joseph B. Bogardus - Manlius NY
Assignee:
Bristol-Myers - New York NY
International Classification:
A61K 966
A61K 942
C07H 1520
C07H 1524
US Classification:
514 33
Abstract:
A stable solution of etoposide in 1-methyl-2-pyrrolidinone is disclosed. The solution can be diluted with a parenteral vehicle to yield an infusion solution containing up to 10 mg/ml etoposide activity without rapid etoposide crystallization. Solutions having etoposide concentration of as high as 500 mg/ml can also be prepared and used to fill gelatin capsules.

D.sub.4 T Polymorphic Form 1 Process

US Patent:
5608048, Mar 4, 1997
Filed:
Jun 5, 1995
Appl. No.:
8/465208
Inventors:
Rajesh B. Gandhi - Liverpool NY
Joseph B. Bogardus - Manlius NY
Peter M. Garofalo - Syracuse NY
Timothy R. Marr - Deruyter NY
Robert K. Perrone - Liverpool NY
Murray A. Kaplan - Syracuse NY
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07H 1906
US Classification:
536 282
Abstract:
The present invention concerns a novel process using controlled cooling for obtaining d. sub. 4 T polymorphic Form I from a mixture containing one or more of polymorphic Forms I, II and III. Compound d. sub. 4 T has been approved for use in the treatment of AIDS.

Lyophilized Or Precipitated Cephalosporin Zwitterion And Salt Combination

US Patent:
4808617, Feb 28, 1989
Filed:
Jan 9, 1987
Appl. No.:
7/001945
Inventors:
Murray A. Kaplan - Syracuse NY
Nageswara R. Palepu - Dublin OH
Joseph B. Bogardus - Manlius NY
Assignee:
Bristol-Myers Company - New York NY
International Classification:
A61K 31545
C07D50146
US Classification:
514202
Abstract:
Amorphous solid formed by lyophilization or cosolvent precipitation of an aqueous solution of 7-[. alpha. -(2-aminothiazol-4-yl)-. alpha. -(Z)-methoximinoacetamido]-3-[(1-m ethyl-1-pyrrolidinio)-methyl[-3-cephem-4-carboxylate zwitterion and a salt or mixture of salts from a selected particular group is a broad spectrum antibiotic composition and has better temperature stability at least up to 45. degree. C. than the zwitterion. The salt is one wherein the cation is selected from the group consisting of sodium, lithium, calcium, and magnesium and the anion is selected from the group consisting of chloride, bromide, and iodide. The molar ratio of zwitterion to salt ranges from about 0. 5:1 to about 2:l.

Antiviral, Highly Water Soluble, Stable, Crystalline Salts Of 2', 3'-Dideoxyinosine, 2', 3'-Dideoxy-2', 3'-Didehydrothymidine And 2', 3'-Dideoxy-2'-Fluoroinosine

US Patent:
6207650, Mar 27, 2001
Filed:
Dec 6, 1991
Appl. No.:
7/805729
Inventors:
Joseph B. Bogardus - Manlius NY
Murray A. Kaplan - Syracuse NY
Robert K. Perrone - Liverpool NY
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K31/70
7
C07H19/073
19/173
19/20
US Classification:
514 45
Abstract:
Provided are very highly water soluble, stable, crystalline salts of 2',3'-dideoxy-2',3'-didehydrothymidine ("d4T"), 2',3'-dideoxyinosine ("ddI"), and 2',3'-dideoxy-2'-fluoroinosine ("F-ddI"). Such salts are useful as intermediates or as antiviral agents.

Stable Solutions Of Mitomycin C

US Patent:
5216011, Jun 1, 1993
Filed:
Sep 1, 1989
Appl. No.:
7/401713
Inventors:
Mehdi Paborji - Liverpool NY
Joseph B. Bogardus - Manlius NY
Shreeram N. Agharkar - Fayetteville NY
William P. Coppola - Canastota NY
Assignee:
Bristol-Myers Squibb Co. - New York NY
International Classification:
A61K 3140
US Classification:
514410
Abstract:
A stable solution of mitomycin C in propylene glycol or propylene glycol/water is disclosed. The solutions have an acceptable shelf-life of greater than 24 months at 4. degree. C. and can be injected directly or diluted with water or other aqueous parenteral vehicle for parenteral administration.

Temperature Stable Crystalline Di(1-Methyl-2-Pyrralidinone) And Di(N-Formylpyrrolidine) Adducts Of Cephalosporin Derivatives

US Patent:
4680389, Jul 14, 1987
Filed:
Jan 10, 1986
Appl. No.:
6/817646
Inventors:
Murray A. Kaplan - Syracuse NY
Joseph B. Bogardus - Manlius NY
Robert A. Lipper - Manlius NY
Assignee:
Bristol-Myers Company - New York NY
International Classification:
C07D50146
US Classification:
540222
Abstract:
Crystalline adducts of 7-[(Z)-2-methoxyimino-2-(2-aminothiazol-4-yl)acetamido-3-[(1-methyl-1-pyrr olidinium)methyl]-3-cephem-4-carboxylate selected from the group consisting of the di(1-methyl-2-pyrrolidinone) adduct and the di(N-formyl pyrrolidine) adduct and salt complexes thereof have been found to be stable at even high temperatures. The crystalline adducts are prepared by forming an admixture of adducting agents, zwitterions and seed adduct crystals and inducing crystallization followed by isolating the crystals. A process for preparing adduct salt complexes is also disclosed. Crystalline zwitterion can be formed by slurrying the adducts in a solvent which removes the adducting agents.

3-Propenzl Cephalosporin Isomer Separation Process And Derivative

US Patent:
4727070, Feb 23, 1988
Filed:
Nov 25, 1985
Appl. No.:
6/801272
Inventors:
Murray A. Kaplan - Syracuse NY
Michael W. Lovell - Syracuse NY
Joseph B. Bogardus - Manlius NY
Assignee:
Bristol-Myers Company - New York NY
International Classification:
A61K 31545
C07D50112
US Classification:
514202
Abstract:
The antibiotic 7-[D-2-amino-2-(4-hydroxyphenyl)acetamido]-3-[(Z)-1-propenyl]ceph-3-em-4-c arboxylic acid (BMY-28100) forms imidazolidinone derivatives on reaction with ketones. These derivatives are useful in pharmaceutical dosage forms and as intermediates for separation thereof from mixtures containing the [(E)-1-propenyl]isomer of the antibiotic.

Possible Relatives

James F Bogardus  Janet M Bogardus  Jason S Bogardus  Jennifer L Bogardus  John R Bogardus  Justin Bogardus  Kevin S Bogardus  Joseph C Last  Joseph S Stan  Joseph M Standish 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.